Health knowledge made personal
WellPage for Hemophilia A
+ Bookmark › Share
Email Digg del.icio.us Reddit icon StumbleUpon Technorati
Go
Search posts:

Hemophilia A - Articles

Is Hemophilia treatment preventative? by Mark Levin Posted Thu 17 Jun 2010 3:45am Hemophilia A is the most common type of hemophilia.  It is also known as factor VIII  deficiency or classic hemophilia. It is largely an inherited disorder in which one... mutation. There are different levels of hemophilia: mild, moderate, and severe: • People with mild hemophilia (6% to 49% factor level) usually have problems with bleeding only Read on »
Hemophilia - For Males Only by Anthony R. Patient Expert Posted Fri 21 Nov 2008 4:47pm 2 Comments Hemophilia is the excessive bleeding that occurs from minor injuries or even without any obvious reason, owing to the absence or abnormality of a clotting factor in the blood. Hemophilia is passed from a parent to a child. Men with hemophilia pass the gene on to their daughters, but not their sons. These daughters’ blood usually clots Read on »
Health Tip: Possible Complications of Hemophilia by HealthFinder Posted Thu 27 Jan 2011 12:00pm to additional problems (HealthDay News) -- Hemophilia is a disorder in which the blood doesn't properly clot, so stopping bleeding becomes more difficult. The U.S. Centers for Disease Control and Prevention says possible complications of hemophilia include Read on »
How do you diagnose hemophilia? by pathologystudent Posted Thu 11 Feb 2010 8:36am signs? Thanks! A. Great questions! In hemophilia A, the problem is that you don’t have factor VIII. In hemophilia B, you don’t have factor IX. The PT (INR) measures... Q. In one of my other courses, the professor was discussing hemophilia. He states that the prothrombin time (PT) is normal, the partial thromboplastin time (PTT Read on »
Hemophilia - Pipeline Assessment and Market Forecasts to 2017 by GlobalData Posted Tue 01 Feb 2011 9:12am The Hemophilia Therapeutics Market is forecasted to become a $10 billion market by 2017 The global hemophilia therapeutics market for 2009 was valued at $6.5 billion... in the discovery and preclinical phase. A key development in the hemophilia therapeutics market has been that Grifols agreed to purchase Talecris Biotherapeutics for $3billion. This deal Read on »
Gene Therapy Helps Patients with Hemophilia B by Medline Plus Posted Mon 12 Dec 2011 1:44pm therapy technique boosted the production of a vital blood clotting factor in six people with hemophilia B, according to new research supported by the National Institutes of Health. The therapy could give patients a long-term solution for preventing prolonged bleeding episodes and spontaneous bleeding. People with hemophilia bleed more following trauma than Read on »
Researchers Harness The Power Of Plants To Fight Hemophilia by Ed H. Doctor of Pharmacy Posted Wed 31 Mar 2010 10:36am Hemophilia, a disease linked with legends of European monarchs, frail heirs and one flamboyant charlatan called Rasputin, still afflicts many people today. And the very treatments that can help can also put patients’ lives at risk. The standard treatment is infusion with an expensively produced protein that helps the blood to clot. But in some Read on »
A Drug To Treat Hemophilia Was Polluted With Hepatitis Viruses And HIV by Ed H. Doctor of Pharmacy Posted Tue 19 Oct 2010 5:30pm This is the story of a boy who had hemophilia, a bleeding disorder that resulted in pain, disability and death before adulthood. A new medicine was developed which brought an end to suffering and increased longevity in persons with hemophilia.  The effect of the new medicine was like magic. It was a remarkable revolutionary advancement Read on »
Celebrex for hemophilia by Mark Levin Posted Fri 03 Jun 2011 6:13pm Individuals with bleeding disorders may require analgesics like do other patients. This includes individuals with hemophilia and joint pain associated with acute... be used. The National Hemophilia Foundatoion and Candadian Hemophila Foundation both recommend coution in using it. I quote: " 1.Caution is advised with use of COX-2 inhibitors Read on »
Hemophilia Drug Can Damage Heart by Medline Plus Posted Wed 03 Nov 2010 1:04pm . The drug, NovoSeven, is a genetically engineered version of factor VII, a key protein missing in some people with the bleeding disease hemophilia Read on »